Published On : 09 july 2025
• Global Endovenous Laser Ablation (EVLA) Device market was valued at USD 316 million in 2024 and is projected to grow from USD 341 million in 2025 to USD 507 million by 2032, exhibiting a CAGR of 7.3% during the forecast period.
Email: help@intelmarketresearch.com +91 9169164321
• Endovenous Laser Ablation (EVLA) Devices are minimally invasive medical instruments designed for the treatment of venous disorders such as varicose veins and chronic venous insufficiency. These devices deliver targeted laser energy through an optical fiber inserted into the affected vein, inducing thermal damage to the vessel wall. This process leads to vein closure and eventual absorption by the body, restoring normal blood flow. EVLA is preferred over traditional surgical methods due to its reduced recovery time, lower complication rates, and outpatient procedure feasibility.
Email:
•Endovenous Laser Ablation (EVLA) Devices
•Radiofrequency Ablation (RFA) Devices
•Non-Thermal, Non-Tumescent (NTNT) Devices
• Great Saphenous Vein (GSV) ablation
• Small Saphenous Vein (SSV) ablation
• Perforator veins treatment
• Others (including venous ulcers and reticular veins)
Email: help@intelmarketresearch.com
•AngioDynamics (U.S.)
•Lumenis (Israel)
•Biolitec (Germany)
•Dornier MedTech (Germany)
•EUFOTON S.R.L (Italy)
•Vascular Solutions (U.S.)
Email: help@intelmarketresearch.com +91 9169164321
